Literature DB >> 25892334

Insurance status and time to completion of surgery for breast cancer.

Matthew Solomon1, Colin T Cochrane1, David A Grieve1,2.   

Abstract

BACKGROUND: The aim of this study was to compare the time to re-operation, following inadequate loco-regional surgery for breast cancer, between the public and private sectors of the Sunshine Coast region.
METHODS: A retrospective review was performed of the medical records of all female patients undergoing guide wire-localized, breast-conserving surgery at Nambour General Hospital and in the local private sector from January 2009 until April 2010. The dates of initial consultation, operation, post-operative consultation and any subsequent reoperation were recorded.
RESULTS: One hundred and seventeen public sector patients and 113 private sector patients were identified during the study period. Thirty-seven public patients (32%) and 46 private patients (41%) required re-operation. This difference was not significant (χ(2) = 2.06, degrees of freedom (df) = 1, P = 0.15). The mean time and standard error from the initial consultation to the first operation and re-operation in the public sector was 26 (2.3) and 62 (3.8) days, and in the private sector was 12 (1.2) and 30 (4.4) days, respectively P < 0.001. On average, 70% of public patients and 96% of private patients completed the surgical component of their breast cancer management within the Queensland Health-recommended time frame of 30 days (χ(2) = 26, df = 1, P < 0.001).
CONCLUSION: While experiencing similar rates of re-operative surgery in breast cancer management in the public and private sectors, the private sector deals with this issue in a more time efficient manner. An opportunity for intervention by quarantining theatre time is explored to improve the public sector time management.
© 2015 Royal Australasian College of Surgeons.

Entities:  

Keywords:  adjuvant chemotherapy; breast cancer; breast-conserving surgery; health insurance; loco-regional treatment

Mesh:

Year:  2015        PMID: 25892334     DOI: 10.1111/ans.13107

Source DB:  PubMed          Journal:  ANZ J Surg        ISSN: 1445-1433            Impact factor:   1.872


  1 in total

1.  Time to surgery among women treated with neoadjuvant systemic therapy and upfront surgery for breast cancer.

Authors:  Ipshita Prakash; Samantha M Thomas; Rachel A Greenup; Jennifer K Plichta; Laura H Rosenberger; Terry Hyslop; Oluwadamilola M Fayanju
Journal:  Breast Cancer Res Treat       Date:  2020-11-18       Impact factor: 4.872

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.